The association between depression and coronary heart disease incidence

Drugs of Today

Volumn 36, Issue 10, 2000, Pages 715-724

  Vaccarino, V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DEPRESSION; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; PREVALENCE; REVIEW; SUDDEN DEATH;

EID: 0033659185     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.10.599210     Document Type: Review

References (110)

1. Increasing burden of cardiovascular disease. Current knowledge and future directions for research on risk factors
2. Prediction of coronary heart disease using risk factor categories
3. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
4. Cardiovascular disease and risk factor epidemiology: A look back at the epidemic of the 20th century
5. Global mortality, disability, and the contribution of risk factors: Global burden of disease study
6. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study
7. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
8. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults
9. Depression and cardiovascular diseases
10. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer
11. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up
12. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
13. Depression as a risk factor for ischemic heart disease in men: Population based case-control study
14. Depression is a risk factor for coronary artery disease in men
15. Depressive symptoms and 6-year mortality among elderly community-dwelling women
16. Association between depressive symptoms and mortality in older women
17. Depressive symptoms and increased risk of stroke mortality over a 29-year period
18. Affective disorders and mortality: A general population study
19. Depression following myocardial infarction
20. Gender, depression and one-year prognosis after myocardial infarction
21. Depression and long-term mortality risk in patients with coronary artery disease
22. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)
23. Major depressive disorder predicts cardiac events in patients with coronary artery disease
24. Depression and outcome in acute myocardial infarction
25. Personality, disease severity, and risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction
26. Mental health status as a predictor of morbidity and mortality: A 15-year follow-up of members of a health maintenance organization
27. Changes in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly)
28. A systematic review of the mortality of depression
29. Depression and the course of coronary artery disease
30. The relationship of depression to cardiovascular disease
31. Sad, glad, or mad hearts? Epidemiological evidence for a causal relationship between mood disorders and coronary artery disease
32. Psychosocial factors in the aetiology and prognosis of coronary heart disease: Systematic review of prospective cohort studies
33. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy
34. Depression and medical illness
35. Effect of mental stress on myocardial ischemia during daily life
36. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls
37. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
38. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia
39. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
40. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography
41. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis
42. Functional and morphologic changes in heart lung preparations following administration of adrenal hormones
43. Acute-phase proteins and other systemic responses to inflammation
44. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis
45. Resting plasma catecholamine concentrations in patients with depression and anxiety
46. High plasma NE levels in patients with major affective disorder
47. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine: Relationship to hypothalamic-pituitary-adrenal axis function in depression
48. Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics
49. Receptor sensitivity and the mechanism of action of antidepressant treatment
50. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output
51. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients
52. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease
53. Heart rate and cardiovascular mortality: The Framingham Study
54. Influence of heart rate on mortality after acute myocardial infarction
55. Endothelial dysfunction in response to psychosocial stress in monkeys
56. The role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis
57. Power-law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplant
58. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control
59. Frequency domain measures of heart period variability and mortality after myocardial infarction
60. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
61. Inter-relationship between effect on heart rate variability and effect on outcome by β-blockers in the Beta Blocker Heart Attack Trial (BHAT)
62. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era
63. Impact of reduced heart rate variability on risk for cardiac events: The Framingham heart study
64. Power-law relationship of heart rate variability as a predictor of mortality in the elderly
65. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men
66. Cardiac autonomic function and incident coronary heart disease: A population-based case-cohort study
67. Heart rate variability and sudden cardiac death secondary to coronary artery disease during ambulatory electrocardiographic monitoring
68. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia
69. Variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death
70. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia
71. The effect of vagus nerve stimulation upon vulnerability of the canine ventricle
72. Electrical stability of acutely ischemic myocardium: Influences to heart rate and vagal stimulation
73. Adrenergic effects on ventricular vulnerability
74. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias
75. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores
76. Association of depression with reduced heart rate variability in coronary artery disease
77. Psychosocial factors and heart rate variability in healthy women
78. Increases in heart rate variability with successful treatment in patients with major depressive disorder
79. Plasma catecholamines and essential hypertension: An analytical review
80. Inflammation, infection, and cardiovascular risk. How good is the evidence?
81. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
82. Novel inflammatory markers of coronary risk. Theory versus practice
83. Indicators of immune activation in major depression
84. Association of interleukin-6 and other biological variables with depression in older people living in the community
85. Platelets and coronary heart disease: Potential psychophysiologic mechanisms
86. Exaggerated platelet reactivity in major depression
87. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients
88. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease
89. Fibrinopeptide A and β-thromboglobulin in patients with angina pectoris and acute myocardial infarction
90. Fibrinopeptide A, platelet factor 4, and β-thromboglobulin levels in coronary heart disease
91. Plasma betathromboglobulin in acute myocardial infarction
92. Circulating platelet products in unstable angina pectoris
93. Platelet release and thromboxane synthesis in symptomatic coronary artery disease
94. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies
95. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies
96. Price of adaptation: Allostatic load and its health consequences. MacArthur studies of successful aging
97. Stress and the individual: Mechanisms leading to disease
98. Mortality after bereavement: A prospective study of 95,647 persons
99. Mortality after bereavement
100. Effects of Iraqui missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians
101. Sudden cardiac death triggered by an earthquake
102. Stress-induced pulse pressure change predicts women's carotid atherosclerosis
103. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men
104. Smoking, smoking cessation and major depression
105. Depression and the dynamics of smoking: A national perspective
106. Major depression and medication adherence in elderly patients with coronary artery disease
107. Depression, adherence behavior, and coronary disease outcomes
108. Smoking and major depression: A casual analysis